by Sarah Thompson Anthony Macdonald Jake Mitchell The near quadrupling of vitamin maker Blackmores' share price over the past 12 months has put a potential $1 billion-plus price tag on high-profile rival Swisse Wellness, which has investment bank Goldman Sachs in its corner testing the appetite of potential buyers.
product_or_material_produced: Goldman Sachs, investment bank